Saturday, 20th April 2024
To guardian.ng
Search

“CureChat’, Mobile App to Save Lives Goes Live

By Bankole Orija
09 October 2015   |   6:01 am
CURECHAT, a new app aimed at reducing loss of lives caused by ignorance through effective public health awareness has gone live in Nigeria and the promoters are happy about it. It is premised on providing for the long needed technological solution to bridge the gap between doctors and patients in Nigeria. CureChat was launched in…
Cure Chat. PHOTO : smileandmobile

Cure Chat. PHOTO : smileandmobile

CURECHAT, a new app aimed at reducing loss of lives caused by ignorance through effective public health awareness has gone live in Nigeria and the promoters are happy about it.

It is premised on providing for the long needed technological solution to bridge the gap between doctors and patients in Nigeria.

CureChat was launched in September 2015.

According to the promoters, malnutrition, malaria, typhoid among other illnesses have been burning problems in Nigeria and the bordering countries in Africa for many decades without complete eradication.

Folabi Karunwi, Founder/CEO, CureChat Ltd, said that these public health issues have been a major burden on the country’s economy affecting the day-to-day life of every citizen.

CureChat Ltd, he said is up for the Challenge

According to Karunwi, “Lack of health awareness has been a major cause of the number of deaths reported in Nigeria yearly. There is a clear need to identify an approach to creating public health awareness in a rather effective manner in order to reduce the number of loss of lives caused by ignorance in Nigeria and Africa.

CureChat Ltd pitches their new startup under the limelight that people nowadays have easier access to the internet and new technology than in the past, which can be helpful in creating more awareness on public health. Both teens and adults are obsessed with their smartphones and clearly show a higher tendency to use new technology to gain access to information and seek professional advice.

0 Comments